Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Celgene Corp (CELG)

89.39 -0.23 (-0.26%)

04-20 14:41

Open:

89.42

Pre. Close:

89.62

High:

90.13

Low:

88.25

Volume:

2,957,260

Market Cap:

67237M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

91.839 - 92.457

92.457 - 92.969

Low:

88.092 - 88.691

88.691 - 89.187

Close:

88.744 - 89.715

89.715 - 90.519

Technical analysis  (as of: 2018-04-20 1:06:25 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 107.42     One year: 125.47

Support:

Support1: 87.20    Support2: 84.25

Resistance:

Resistance1: 91.97    Resistance2: 107.42

Pivot:

89.08

Moving Averages:

MA(5): 90.37     MA(20): 88.59

MA(100): 97.23     MA(250): 114.95

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.48

%K %D:

%K(14,3): 75.30     %D(3): 82.23

RSI:

RSI(14): 49.56

52-Week:

High: 147.17  Low: 84.25  Change(%): -27.3

Average Vol(K):

3-Month: 733106  10-Days 438837

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CELG has closed below upper band by 41.7%. Bollinger Bands are 34.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-20T01:53:19-04:00
Portfolio Strategy Report: Why Investors Should Build Shares In Bioscience Stocks

2018-04-19T17:51:00-04:00
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Celgene Corporation (CELG) and Encourages Investors to Contact the Firm

2018-04-19T07:48:00-04:00
Celgene Corporation Announces Changes to Its Board of Directors

2018-04-17T15:37:55-04:00
Evelo Biosciences Files For U.S. IPO

2018-04-17T11:24:51-04:00
Project $1M: Q1 2018 Has Been A Rollercoaster Ride!

2018-04-17T07:30:00-04:00
Celgene Corporation to Webcast at Upcoming Investor Conferences

2018-04-17T05:22:26-04:00
Wedgewood Partners Q1 2018 Client Letter - Hello Volatility, My Old Friend, I've Come To Talk With You Again

2018-04-16T15:18:27-04:00
Victory Formation Long/Short Portfolio Update - Buy Gold, Oil And Disney

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

752.18

Shares Float (M)

748.50

% Held by Insiders

0.50

% Held by Institutions

84.10

Shares Short (K)

15648

Shares Short Prior Month (K)

8920

Stock Financials

EPS

6.860

EPS Est. Current Year

7.320

EPS Est. Next Year

8.810

EPS Est. Next Quarter

2.030

Forward EPS

10.182

Book Value (p.s.)

9.750

PEG Ratio

0.52

Profit Margin

19.94

Operating Margin

42.14

Return on Assets (ttm)

10.1

Return on Equity (ttm)

43.5

Qtrly Rev. Growth

16.9

Gross Profit (p.s.)

16.668

Sales Per Share

EBITDA (p.s.)

7.006

Qtrly Earnings Growth

Operating Cash Flow (M)

5250.00

Levered Free Cash Flow (M)

4550.00

atoplab.com

Valuation

P/E

13.06

P/E Growth Ratio

P/BV

9.19

P/S

4036263424.00

P/CF

12.83

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2014-06-26

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.